Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$191.17 - $325.63 $2.03 Million - $3.45 Million
-10,607 Reduced 7.07%
139,482 $45.4 Million
Q4 2023

Feb 07, 2024

BUY
$160.99 - $215.69 $514,524 - $689,345
3,196 Added 2.18%
150,089 $28.6 Million
Q3 2023

Nov 02, 2023

BUY
$194.33 - $283.97 $308,401 - $450,660
1,587 Added 1.09%
146,893 $29.2 Million
Q2 2023

Aug 07, 2023

SELL
$223.05 - $302.68 $643,053 - $872,626
-2,883 Reduced 1.95%
145,306 $41.5 Million
Q1 2023

May 09, 2023

SELL
$175.41 - $217.92 $40,168 - $49,903
-229 Reduced 0.15%
148,189 $32.1 Million
Q4 2022

Feb 09, 2023

BUY
$204.38 - $296.82 $72,759 - $105,667
356 Added 0.24%
148,418 $30.5 Million
Q3 2022

Nov 09, 2022

SELL
$195.21 - $310.53 $18.6 Million - $29.5 Million
-95,126 Reduced 39.12%
148,062 $41.2 Million
Q2 2022

Aug 10, 2022

BUY
$115.91 - $214.48 $27 Million - $50 Million
232,996 Added 2286.07%
243,188 $46.5 Million
Q1 2022

May 09, 2022

BUY
$127.96 - $207.36 $29,174 - $47,278
228 Added 2.29%
10,192 $2.11 Million
Q4 2021

Feb 09, 2022

SELL
$165.13 - $241.83 $6.57 Million - $9.63 Million
-39,802 Reduced 79.98%
9,964 $1.78 Million
Q3 2021

Nov 09, 2021

BUY
$163.99 - $235.57 $49,033 - $70,435
299 Added 0.6%
49,766 $10.2 Million
Q2 2021

Aug 10, 2021

SELL
$131.45 - $201.49 $1.87 Million - $2.87 Million
-14,243 Reduced 22.36%
49,467 $9.39 Million
Q1 2021

May 10, 2021

BUY
$92.73 - $142.05 $381,862 - $584,961
4,118 Added 6.91%
63,710 $8.3 Million
Q4 2020

Feb 08, 2021

BUY
$67.44 - $103.72 $3.33 Million - $5.12 Million
49,346 Added 481.61%
59,592 $6.18 Million
Q3 2020

Nov 06, 2020

SELL
$42.79 - $75.8 $8,558 - $15,160
-200 Reduced 1.91%
10,246 $776,000
Q2 2020

Aug 05, 2020

BUY
$27.25 - $47.53 $284,653 - $496,498
10,446 New
10,446 $495,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.